Quinolines: a new hope against inflammation

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Existing anti-inflammatory drugs often cause adverse side effects.
• The quinoline scaffold presents a novel template for developing new anti-inflammatory agents.
• Quinoline derivatives can be classified by their substitution patterns or fusion with other heterocycles.

Purpose of the Study:

• To review the discovery and development of quinoline derivatives as anti-inflammatory agents.
• To focus on quinoline derivatives targeting specific inflammatory pathways and targets.

Main Methods:

• Literature review of quinoline derivatives with anti-inflammatory properties.
• Classification of quinoline derivatives based on structural features.
• Identification of quinoline derivatives as inhibitors of specific enzymes and receptors.

Main Results:

• Quinoline derivatives have been identified as inhibitors of cyclooxygenase (COX).
• Several quinoline compounds show efficacy as phosphodiesterase 4 (PDE4) inhibitors.
• Tumour necrosis factor-α converting enzyme (TACE) and transient receptor potential vanilloid 1 (TRPV1) antagonists based on quinoline are also discussed.

Conclusions:

• Quinoline derivatives represent a valuable class of compounds for the development of novel anti-inflammatory drugs.
• Targeting COX, PDE4, TACE, and TRPV1 with quinoline-based agents offers potential therapeutic benefits.
• Further research into quinoline derivatives may lead to safer and more effective anti-inflammatory therapies.